Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

NCT06904872 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome
Malabsorption Syndromes
Short Gut Syndrome
Post-Op Complication
Functional Gastrointestinal Disorders

Interventions

DRUG: Crofelemer Powder for Oral Solution
DRUG: Matched Placebo Powder for Oral Solution

Sponsor

Napo Therapeutics, S.p.A.